News

ASE Technology Holding's Q2 earnings beat estimates as AI-driven LEAP and ATM demand boosts revenues, margins and the full-year ATM outlook.

PLTR's second-quarter revenues are expected to jump 80% as AI-driven demand lifts its government and commercial businesses.

Ross Stores (ROST) is in focus after its May 21, 2026 earnings call, where management reported a 17% comparable store sales gain and raised full year guidance, followed by a 15.8% stock move. See our latest analysis for Ross Stores. At a US$252.57 share price, Ross Stores has shown firm momentum, with a 30 day share price return of 19.19% and a 1 year total shareholder return of 86.02%. This suggests investors are reassessing its growth and risk profile after strong earnings updates and...

In the past few days, AXT, Inc. reported sharply higher second-quarter 2026 sales of US$47.59 million and net income of US$11.13 million, and disclosed a long-term indium phosphide supply and capacity-reservation agreement with Lumentum Operations, LLC backed by up to US$87,500,000 in deposits applied as shipment credits. Alongside these results, AXT moved to expand board expertise, lowered its shareholder meeting quorum threshold, and secured multi‑year indium phosphide commitments that tie...

Arista Networks recently reported a strong first quarter of fiscal 2026 and raised its full-year revenue guidance, while preparing to release its second-quarter results on August 4, supported by growing demand for AI-focused data center networking solutions and new platforms such as the 7060XE7 Series. Institutional buying interest and Arista’s expanding role as an AI infrastructure supplier suggest that investors are closely watching how its AI-centric products and partnerships translate...

Dominion Energy (NYSE:D) reported second-quarter 2026 operating earnings of $0.79 per share, including $0.03 per share from renewable natural gas 45Z credits, while GAAP earnings were $0.37 per share. The utility reaffirmed its full-year operating earnings, credit, dividend and long-term growth guid

Chevron (NYSE:CVX) reported second-quarter 2026 earnings of $12.1 billion, or $6.11 per share, as higher upstream realizations, production volumes and refining margins lifted results. Adjusted earnings were $12 billion, or $6.06 per share, while cash flow from operations excluding working capital to

APPS heads into fiscal Q1 2027 earnings with expected double-digit revenue growth, powered by ODS, AGP, AI tools and global partnerships.

Moderna's Q2 revenue tops estimates, but shares fall after its phase III norovirus vaccine study misses early success criteria.

Ultra Clean heads into Q2 earnings with AI-driven chip demand and rising fab activity, but a premium valuation and stiff competition raise the bar for execution.

Investing.com -- Short sellers have increased their positions in SpaceX before two major events next week: the company's first earnings report as a public company and the release of hundreds of millions of locked-up shares.

Markel Group's Q2 results reflect stronger underwriting and investment income, but weaker performance in the Industrial and Financial segments hurt earnings.

Unusual Machines heads into Q2 results with surging revenue expectations as defense demand, new capacity and strategic investments shape the outlook.

GDDY tops Q2 earnings and revenue estimates as growth across both segments, rising ARPU, and accelerating Airo adoption support results and guidance.

RDDT tops Q2 earnings and revenue estimates as ad demand, pricing and user growth fuel monetization, with Q3 guidance pointing to continued momentum.

FRSH heads into Q2 earnings with estimated revenue growth of 14.1%, backed by EX momentum and cost discipline as CX growth stays muted

Wall Street offered mixed views on Apple’s outlook after earnings, while Stocktwits retail traders largely shrugged off the selloff and stayed bullish.

GLW's AI optics growth, stronger cash flow and rising estimates support upside, but a premium valuation leaves little room for execution misses.

SATL heads into Q2 earnings with revenue seen more than doubling as defense deals, recurring imagery sales and cash-flow risks shape the outlook.

DXCM's Q2 earnings and revenues beat estimates as global demand, broader access and margin expansion fuel stronger 2026 guidance.

Astera Labs Q2 earnings are likely to gain from strong AI connectivity momentum, but margin pressure, rich valuation, and rising competition could keep investors cautious.

OVBC's second-quarter 2026 earnings face pressure from higher credit loss provisions despite stronger net interest income and continued loan growth.

LPLA's Q2 results benefit from strong revenue and advisory asset growth while boosting its buyback authorization. Yet, higher expenses partly offset the gains.

IR beats Q2 earnings and revenue estimates, raises its 2026 sales outlook and reports stronger orders, cash flow and M&A momentum.

Novo Nordisk and Eli Lilly compete in the same blockbuster drug class, yet their 2026 earnings tell dramatically different stories about which company holds the upper hand heading into a pivotal summer of reports and pricing resets.

EMR heads into Q3 fiscal 2026 earnings with expected sales and EPS growth as automation strength and the AspenTech buyout face cost pressures.

CBOE's Q2 earnings beat estimates. Record Options revenues, broad-based growth and stronger margins drove a raised 2026 revenue outlook.

Globus Medical will report Q2 results on Aug. 6. Investors will be keen to know whether Enabling Technologies and Spine strength aid revenue & earnings growth.

WESCO tops Q2 earnings and revenue estimates as data center sales surge, backlog hits a record, and management raises its 2026 outlook.

SpaceX (SPCX) just got some very good news. The U.S. Space Force awarded the company two task orders worth a combined $1.6 billion to launch 18 Falcon 9 rockets carrying military satellites. The news was announced on July 29. Every launch will lift off from Vandenberg Space Force Base in ...